Fusion Biopsy Market
                     Adroit Market Research
Fusion Biopsy Market
Size 2020, By Biopsy Route (Transrectal, Transperineal) End Use (Hospitals, 
Diagnostic Centers, Ambulatory Care Centers) Region (North America, 
Europe, Asia Pacific, Latin America, Middle East and Africa) and Forecast 
2021 to 2028
Single Use License: US$ 4400 Request Sample
+1 (214) 884-6068               [email protected] www.adroitmarketresearch.com
Adroit Market Research
Fusion Biopsy Market Size and Share 2028
• The global fusion biopsy market is projected to reach USD 1,001.2 million by 2028, growing at a CAGR of 11.1%. Growing 
incidence of prostate cancer, high specificity of fusion biopsy, and increasing acceptance of multiparametric MRI in 
prostate cancer care are some of the factors driving the growth of the global fusion biopsy market.
• Adroit Market Research report on global Fusion biopsy market gives a holistic view of the market from 2018 to 2028, which 
includes factors such as market drivers, restraints, opportunities and challenges. The market has been studied for historic 
years from 2018 to 2019, with the base year of estimation as 2020 and forecast from 2021 to 2028. The report covers the 
current status and future traits of the market at global as well as country level. In addition, the study also assesses the key 
players based on their product portfolio, geographic footprint, strategic initiatives and overall revenue. Prominent players 
operating in the global Fusion biopsy market have been studied in detail.
• Prostate cancer is the second most frequently diagnosed cancer worldwide, and the fifth leading cause of cancer death in 
men. Most guidelines recommend screening for prostate cancer for well-informed men with more than seven to ten years 
of life expectancy. The process involves performing a clinical history, digital rectal examination (DRE) and serum testing of 
prostate specific antigen (PSA). Prostate biopsy is performed on the basis of screening results, and remains the gold 
standard for diagnosis.
+1 (214) 884-6068               [email protected] www.adroitmarketresearch.com
Adroit Market Research
Fusion Biopsy Market Size and Share 2028
• The global fusion biopsy market is categorized based on biopsy route and end-use. On the basis of biopsy route, the market is 
segmented into transrectal, and transperineal. The transrectal segment dominated the market in 2020. Transrectal ultrasound 
guided prostate biopsy (TRUS-biopsy) is most offered worldwide. Transperineal biopsy (TPP-biopsy), on the other hand, has 
been gaining popularity due to its superior sensitivity and lower rate of sepsis.
• North America dominated the market for fusion biopsy in 2019, while Asia Pacific is set to grow at a highest CAGR due to 
advances in oncology procedures. Key players of the global fusion biopsy market include MedCom, KOELIS, ESAOTE SPA, Focal 
Helathcare, UC-Care Medical Systems Ltd., GeoScan Medical among others.
• Key segments of the global fusion biopsy market
• Biopsy Route Overview, 2018-2028 (USD Million)
• Transrectal
• Transperineal
• End Use Overview, 2018-2028 (USD Million)
• Hospitals
• Diagnostic Centers
• Ambulatory Care Centers
+1 (214) 884-6068               [email protected] www.adroitmarketresearch.com
Adroit Market Research
Fusion Biopsy Market Size and Share 2028
•  Regional Overview, 2018-2028 (USD Million)
• North America
• U.S.
• Canada
• Europe
• Germany
• United Kingdom
• France
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Rest of Asia Pacific
• Latin America
• Middle East & Africa
+1 (214) 884-6068               [email protected] www.adroitmarketresearch.com
Adroit Market Research
About Us
Adroit Market Research is an India-based business analytics and consulting company. Our 
target audience is a wide range of corporations, manufacturing companies, product/technology 
development institutions and industry associations that require understanding of a market’s 
size, key trends, participants and future outlook of an industry. We intend to become our 
clients’ knowledge partner and provide them with valuable market insights to help create 
opportunities that increase their revenues. We follow a code– Explore, Learn and Transform. At 
our core, we are curious people who love to identify and understand industry patterns, create 
an insightful study around our findings and churn out money-making roadmaps. Our analysts 
have tracked high growth markets in chemicals & materials, healthcare & pharmaceuticals, 
semiconductor & electronics, energy & power, food & retail, consumer goods, technology, and 
machinery & equipment sectors across the world to identify new opportunities, potential 
customers, prepare go-to-market (GTM) strategies, identify segments for revenue growth for 
Contact Us companies, and many more.
US Headquarters Phone: +1 (214) 884-6068
Email: [email protected]
3131 McKinney Ave Ste 600 Dallas, 
TX 75204 ,U.S.A 
+1 (214) 884-6068               [email protected] www.adroitmarketresearch.com